Literature DB >> 25430433

Reflux and allograft dysfunction: is there a connection?

Brian C Gulack1, James M Meza1, Shu S Lin2, Matthew G Hartwig3, R Duane Davis4.   

Abstract

Despite improving outcomes following lung transplantation, chronic rejection continues to limit survival. The predominant form of chronic rejection, bronchiolitis obliterans syndrome, has been associated with multiple etiologies including aspiration from gastroduodenal reflux. This article reviews the current literature with regards to the incidence of reflux following lung transplantation, the association of reflux with allograft dysfunction and survival, and the success of prevention and treatment of reflux in this patient population. Although antireflux surgery has been demonstrated to be safe in this population and leads to a stabilization of lung function in patients with reflux, there have not been definitive data that it improves survival.

Entities:  

Keywords:  Allograft dysfunction; Antireflux surgery; Bronchiolitis obliterans syndrome; Chronic lung allograft dysfunction; Fundoplication; Gastroduodenal aspiration; Gastroesophageal reflux disease; Lung transplantation

Mesh:

Year:  2015        PMID: 25430433     DOI: 10.1016/j.thorsurg.2014.09.006

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  5 in total

Review 1.  Recipient selection process and listing for lung transplantation.

Authors:  Geert M Verleden; Lieven Dupont; Jonas Yserbyt; Veronique Schaevers; Dirk Van Raemdonck; Arne Neyrinck; Robin Vos
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 2.  Esophageal Dysmotility, Gastro-esophageal Reflux Disease, and Lung Transplantation: What Is the Evidence?

Authors:  Richard K Wood
Journal:  Curr Gastroenterol Rep       Date:  2015-12

Review 3.  Current trends in candidate selection, contraindications, and indications for lung transplantation.

Authors:  Ashwini Arjuna; Michael T Olson; Rajat Walia
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 3.005

4.  Recipient Comorbidities for Prediction of Primary Graft Dysfunction, Chronic Allograft Dysfunction and Survival After Lung Transplantation.

Authors:  Jonas Peter Ehrsam; Macé M Schuurmans; Mirjam Laager; Isabelle Opitz; Ilhan Inci
Journal:  Transpl Int       Date:  2022-06-29       Impact factor: 3.842

Review 5.  An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Ashwini Arjuna; Michael T Olson; Rajat Walia; Ross M Bremner; Michael A Smith; Thalachallour Mohanakumar
Journal:  Expert Rev Respir Med       Date:  2020-10-25       Impact factor: 3.772

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.